vs
Side-by-side financial comparison of INNEOVA Holdings Ltd (INEO) and LifeMD, Inc. (LFMD). Click either name above to swap in a different company.
LifeMD, Inc. is the larger business by last-quarter revenue ($60.2M vs $30.8M, roughly 2.0× INNEOVA Holdings Ltd). INNEOVA Holdings Ltd runs the higher net margin — 0.8% vs -6.3%, a 7.1% gap on every dollar of revenue. LifeMD, Inc. produced more free cash flow last quarter ($-944.4K vs $-1.5M).
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
INEO vs LFMD — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.8M | $60.2M |
| Net Profit | $243.0K | $-3.8M |
| Gross Margin | 19.3% | 87.7% |
| Operating Margin | 3.6% | -3.3% |
| Net Margin | 0.8% | -6.3% |
| Revenue YoY | — | 13.0% |
| Net Profit YoY | — | 18.3% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $60.2M | ||
| Q2 25 | $30.8M | $62.7M | ||
| Q1 25 | — | $64.1M | ||
| Q3 24 | — | $53.3M | ||
| Q2 24 | — | $50.7M | ||
| Q1 24 | — | $44.1M | ||
| Q4 23 | — | $44.9M | ||
| Q3 23 | — | $38.6M |
| Q3 25 | — | $-3.8M | ||
| Q2 25 | $243.0K | $-1.6M | ||
| Q1 25 | — | $-183.8K | ||
| Q3 24 | — | $-4.7M | ||
| Q2 24 | — | $-6.9M | ||
| Q1 24 | — | $-6.8M | ||
| Q4 23 | — | $-3.7M | ||
| Q3 23 | — | $-6.1M |
| Q3 25 | — | 87.7% | ||
| Q2 25 | 19.3% | 88.1% | ||
| Q1 25 | — | 86.5% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 90.1% | ||
| Q1 24 | — | 89.6% | ||
| Q4 23 | — | 88.1% | ||
| Q3 23 | — | 87.6% |
| Q3 25 | — | -3.3% | ||
| Q2 25 | 3.6% | -0.7% | ||
| Q1 25 | — | 1.5% | ||
| Q3 24 | — | -7.5% | ||
| Q2 24 | — | -12.4% | ||
| Q1 24 | — | -14.0% | ||
| Q4 23 | — | -4.8% | ||
| Q3 23 | — | -11.8% |
| Q3 25 | — | -6.3% | ||
| Q2 25 | 0.8% | -2.6% | ||
| Q1 25 | — | -0.3% | ||
| Q3 24 | — | -8.7% | ||
| Q2 24 | — | -13.6% | ||
| Q1 24 | — | -15.3% | ||
| Q4 23 | — | -8.3% | ||
| Q3 23 | — | -15.9% |
| Q3 25 | — | — | ||
| Q2 25 | $0.02 | $-0.05 | ||
| Q1 25 | — | $-0.02 | ||
| Q3 24 | — | $-0.13 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | — |
| Total DebtLower is stronger | $2.9M | — |
| Stockholders' EquityBook value | $11.2M | $1.3M |
| Total Assets | $52.6M | $66.0M |
| Debt / EquityLower = less leverage | 0.26× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | $2.1M | $36.2M | ||
| Q1 25 | — | $34.4M | ||
| Q3 24 | — | $37.6M | ||
| Q2 24 | — | $35.7M | ||
| Q1 24 | — | $35.1M | ||
| Q4 23 | — | $33.1M | ||
| Q3 23 | — | $15.3M |
| Q3 25 | — | — | ||
| Q2 25 | $2.9M | $15.9M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q3 25 | — | $1.3M | ||
| Q2 25 | $11.2M | $-1.8M | ||
| Q1 25 | — | $-2.3M | ||
| Q3 24 | — | $-7.7M | ||
| Q2 24 | — | $-4.2M | ||
| Q1 24 | — | $-845.3K | ||
| Q4 23 | — | $3.5M | ||
| Q3 23 | — | $-12.7M |
| Q3 25 | — | $66.0M | ||
| Q2 25 | $52.6M | $73.6M | ||
| Q1 25 | — | $73.6M | ||
| Q3 24 | — | $72.6M | ||
| Q2 24 | — | $63.8M | ||
| Q1 24 | — | $61.5M | ||
| Q4 23 | — | $58.5M | ||
| Q3 23 | — | $40.7M |
| Q3 25 | — | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-301.0K | $-147.1K |
| Free Cash FlowOCF − Capex | $-1.5M | $-944.4K |
| FCF MarginFCF / Revenue | -4.8% | -1.6% |
| Capex IntensityCapex / Revenue | 3.8% | 1.3% |
| Cash ConversionOCF / Net Profit | -1.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $16.1M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-147.1K | ||
| Q2 25 | $-301.0K | $8.6M | ||
| Q1 25 | — | $3.1M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $5.2M | ||
| Q4 23 | — | $5.7M | ||
| Q3 23 | — | $1.1M |
| Q3 25 | — | $-944.4K | ||
| Q2 25 | $-1.5M | $7.8M | ||
| Q1 25 | — | $2.9M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $3.9M | ||
| Q1 24 | — | $5.0M | ||
| Q4 23 | — | $5.6M | ||
| Q3 23 | — | $1.0M |
| Q3 25 | — | -1.6% | ||
| Q2 25 | -4.8% | 12.5% | ||
| Q1 25 | — | 4.6% | ||
| Q3 24 | — | 11.7% | ||
| Q2 24 | — | 7.7% | ||
| Q1 24 | — | 11.4% | ||
| Q4 23 | — | 12.5% | ||
| Q3 23 | — | 2.7% |
| Q3 25 | — | 1.3% | ||
| Q2 25 | 3.8% | 1.3% | ||
| Q1 25 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 0.4% | ||
| Q4 23 | — | 0.2% | ||
| Q3 23 | — | 0.1% |
| Q3 25 | — | — | ||
| Q2 25 | -1.24× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INEO
Segment breakdown not available.
LFMD
| Telehealth Subscription Revenue | $27.3M | 45% |
| Telehealth | $20.0M | 33% |
| Work Simpli Revenue | $12.9M | 21% |
| Product And Services | $2.5M | 4% |
